Tag: MAMMORISKR
PREDILIFE: LÉMAN HOSPITALS COMMIT TO BREAST CANCER PREVENTION WITH THE MAMMORISK(R) TEST – 03/14/2022 at 07:00
LÉMAN HOSPITALS COMMIT TO BREAST CANCER PREVENTION WITH THE MAMMORISK® TEST Paris, France, March 14, 2022, 07:00 CET – PREDILIFE (Euronext Growth: ALPRE FR0010169920), a specialist in innovative pathology risk…